People who registered for Immunity for Health2021 can REWATCH the livestream by logging in via the following link:
Congratulations to Chloé Ackaert, ImmunXperts, a Nexelis Company, Belgium & Tobias Kaeser, North Carolina State University, US for getting awarded for the best pitch!!
On October 14th 2021 Flanders Vaccine is happy to host its sixth edition of Immunity for Health. We hope to meet you again in person in Ghent, Belgium but online participation is also possible.
This year the theme is “Animal models and alternatives for the development of vaccines”.
In recent years substantial progress has been made in reducing and replacing the number of animals used for pre-clinical vaccine research, e.g. through the use of computational immunology to design new vaccine candidates. However, animal experiments remain essential if we want to make the necessary progress in medicine and life science.
The programme will cover the importance of animal models for pre-clinical studies, but also highlight innovative alternatives such as in-vitro and in-silico models for future vaccine development. The challenges in moving forward and beyond animal models in research, such as ethical and regulatory issues will be discussed in a vibrant panel debate at the end of the event.
Renowned experts in the field will share their latest scientific data with us! Research groups and sme’s will be given the opportunity to share their innovative ideas, technologies or new products with the audience during the pitch sessions.
The Flanders Vaccine’s annual event connects scientists, clinicians, industry and other partners, to discuss innovative solutions to stimulate the development of vaccines and immunotherapeutics.
09:00 | Registration & welcome coffee
09:45 | Welcome by Fran Van Heuverswyn, Flanders Vaccine
Morning session: The importance of (innovative) animal models for vaccine development Moderator: Prof. Niels Hellings, UHasselt
10:00 | Dr. Kai Dallmeier, Research Expert Virology, Rega Institute, KU Leuven, Belgium
10:00 | In search for models predicting clinical success; lessons learned from COVID-19
10:30 | Prof. Dr. Christian Münz, Viral Immunobiology, Director of the Institute of Experimental Immunology, University of Zurich, Switzerland
10:00 | Modelling human cellular immune responses in humanized mice
11:00 | Coffee break11:00 |
11:30 | Pitch session
12:30 | Lunch Break & Networking
Afternoon Session: Non-animal alternatives for vaccine development Moderator: Prof. Jo Van Ginderachter, VUB/VIB
14:00 | Prof. Paul Wilmes, Professor Systems Ecology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg
13:45 | Resolving immunogenic exposures from the gut microbiome in human health and disease – Implications for vaccine development
14:30 | Dr. Marie-Emmanuelle Behr-Gross, Scientific Programme Manager, European Directorate for the Quality of Medicines and HealthCare
14:10 | (EDQM), Council of Europe
14:10 | Update on EPAA projects on vaccines
15:00 | Dr. Jeffrey Sachs, Distinguished Scientist, PPDM-Quantitative Pharmacology and Pharmacometrics, MSD, US
15:50 | Challenging Animal Models with Models of Challenges: RSV Finds Pharmacometrics for Leveraging Literature
15:30 | Coffee break
16:00 | Panel debate “Successes & challenges in moving forward and beyond animal models in vaccine R&D”
15:50 | With Dr. Eddy Rommel – Rommel Consulting Partners SRL, Prof. Dr. Joeri Aerts – VUB and Dr. Dirk Jochmans – KU Leuven
16:45 | CLOSING KEYNOTE: Advancing translational research using porcine cancer models: current progress and future applications
16:45 | Dr. Kyle Schachtschneider, Research Assistant Professor, University of Illinois, Chicago, US
17:30 | Pitch Award & Closing word
17:45 | Networking Reception
Pitch your innovative ideas
Young scientists are invited to pitch their promising project results or innovative technologies related to one of the two sessions of Immunity for Health 2021. The scientific committee of Immunity for Health has reviewed all applications and selected the following Pitches. On the day of the event, a reward will be awarded for the best pitch.
- An innovative organoid based oncology platform for humanized vaccine research – Kim Frederix, InnoSer Belgium NV
- Immunopeptidomics as a tool to identify relevant antigens for vaccine development – Geert Baggerman, VITO, University of Antwerp, Belgium
- AI-based decoding of the T-cell repertoire – Sander Wuyts, ImmuneWatch, Belgium
- In vitro dendritic cell-based assays for vaccine immunogenicity assessments – Chloé Ackaert, ImmunXperts, a Nexelis Company, Belgium
- Establishment of outbred pre-exposed pigs as an animal model for Chlamydia trachomatis vaccine development (online) – Tobias Kaeser, North Carolina State University, US
Join the conference as a sponsor or exhibitor!
You can also enlarge the visibility of your company with one of our Conference sponsorships. We can show a short company video or you can choose to become a PLATINUM SPONSOR of the conference, where you will achieve maximum visibility with an exhibition booth, company logo on all communication channels, 3 free full access entry tickets and 4 free online entry tickets.
Check out our sponsorship packages and all the benefits for your organisation! Flanders Vaccine members will receive a 15% discount on all our sponsorship packages.
We can also craft a custom package tailored to your needs.
For more information, contact Fran Van Heuverswyn: email@example.com.
Attending On-site (CommunicatieCampus, Ghent, Belgium + access livestreaming)
- Flanders Vaccine member: 150 EUR (+21% VAT)
- Flanders Vaccine non-member: 200 EUR (+21% VAT)
- Students: 50 EUR (+21% VAT)
Attending Online (access to livestreaming + Q&A)
- Flanders Vaccine member: 80 EUR (+21% VAT)
- Flanders Vaccine non-member: 150 EUR (+21% VAT)
- Students (bachelor/master and PhD students): free of charge
Registration closes at October 7th , 2021
After registration, you will receive a confirmation email and an invoice which can be paid online or by creditcard. After payment and closer to the event, you will receive an email with more practical details, such as the login link for online participation. Please check your mailbox and SPAM the first week of October 2021.
IMPORTANT NOTE: Online participation will be only possible with the email address used for registration.
REGISTRATION IS CLOSED!
ACCESS to the event with COVID SAFE TICKET
Immunity for Health 2021 will be a COVID SAFE EVENT. This implies that every visitor older than 12 years, will have to present a COVID SAFE TICKET (QR-code) and a proof of identification. For people who aren’t residing in Belgium, this is the European digital certificate available at national level. Click here for more information.
Please stay home if you show any signs or symptoms, even when you’re vaccinated.
COVID-19 Travel information
If you are a Belgian resident returning to Belgium or any other person travelling through Belgium and staying at least 48 hours in Belgium, then you must fill out an identification form (Passenger Locator Form). Are you traveling to Belgium by plane? Then you must always fill in the PLF, even if you are staying in Belgium for less than 48 hours or were abroad for less than 48 hours 👉 You can find this form here.
Our PLATINUM sponsor:
This event is supported by our strategic partners:
Founding partners of Flanders Vaccine:
Notifications received upon 1 week before the start of the event, get refunded for 100%. Cancellation requests received less than 1 week before the start of the event won’t be refunded. No-shows on the day of the event, for both on-site and online attendance, will not be refunded and are requested to pay the full fee. Replacement by a colleague is always allowed and should be reported to the organizers.
Please be aware that at the event venue you will need to follow the organizer’s safety policies, as well as local laws and restrictions regarding covid-19.
In the event of a cancellation of the on-site part of Immunity for Health, either government imposed or otherwise, the offer will fall back entirely on the virtual component. On-site participation tickets will then be automatically converted to online participation tickets and the difference in ticket pricing will be reimbursed. A cancellation of the on-site event does not equal a cancellation of your participation. Under no circumstance Flanders Vaccine can be held liable for other costs made in the scope of this event, such as transportation or accommodation costs.